ELOVL4 and Stargardt disease: In the case of Stargardt disease, a large proportion of mutations in ABCA4, ELOVL4 and PROM1 could be targeted with one or more of the currently described CRISPR-based approaches: genome editing, epigenetic repression, base editing or prime editing (Table 3).